HCA Healthcare: Frist transfers 555,500 Hercules units
The per-unit value was based on the average of HCA common stock's high and low prices on November 4, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Thomas F. Frist III, a director and ten percent owner of HCA Healthcare, Inc. (HCA), transferred 555,500 Hercules Holding II units to trusts for the benefit of his children on November 4, 2026, in satisfaction of obligations. The stated price was $503.525 per unit. Hercules Holding II holds 32,282,889 HCA common shares; the transfer did not change the total number of HCA shares Frist may be deemed to beneficially own.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Common Stock, par value $0.01 per share F1, F4 | 555,500 | $503.525 | $279.71M |
| Other | Common Stock, par value $0.01 per share F1, F4 | 555,500 | $503.525 | $279.71M |
| Holding | Common Stock, par value $0.01 per share F2 | -- | -- | -- |
| Holding | Common Stock, par value $0.01 per share F3 | -- | -- | -- |
Footnotes (4)
- F1. Hercules Holding II ("Hercules") holds 32,282,889 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"). Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Hercules, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Hercules partnership units to the extent of: 3,034,522 Shares by the Reporting Person; 9,497 Shares by the Reporting Person's spouse; and 3,965,851 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee.
- F2. This number represents restricted share units payable in Shares, which will be delivered to the Reporting Person on the date he ceases to be a director of the Issuer.
- F3. Frisco Holding II ("Frisco") holds 36,557,141 Shares. Frisco is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Frisco, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Frisco partnership units to the extent of: 1,172 Shares by the Reporting Person; and 11,868,140 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee.
- F4. On November 4, 2026, the Reporting Person transferred a total 555,500 units of Hercules to trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee in satisfaction of obligations. Each of these transfers was made at a price per unit of Hercules equal to $503.525 (the average of the high and low prices of the Shares on November 4, 2026). In each case, these transfers did not change the total number of Shares of which the Reporting Person may be deemed to have beneficial ownership.
Key Figures
Key Terms
pecuniary interest financial
beneficial ownership regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many Hercules units did Thomas F. Frist III transfer in the HCA Form 4?
How was the $503.525 price for the Hercules units determined?
AI-generated analysis. How Rhea-AI works. Not financial advice.